Cytori Therapeutics, Inc. Patents Adipose-Derived Cell Therapy for Cardiovascular Disease in Australia
Published: Oct 10, 2013
SAN DIEGO--(BUSINESS WIRE)--Cytori Therapeutics (NASDAQ:CYTX) has received an Australian patent covering methods of treating cardiovascular disease using adipose-derived regenerative cells (ADRCs). The patent covers the therapeutic use of ADRCs for improving cardiac function and mechanics by preventing the deleterious histopathological and structural changes that occur in the heart following a heart attack (cardiac remodeling).
Help employers find you! Check out all the jobs and post your resume.